ArginMax® Enhances Sexual Function in Pre- and PeriMenopausal Women

April 2, 2008

1 Min Read
ArginMax® Enhances Sexual Function in Pre- and PeriMenopausal Women

HONOLULU, Hawaii—A recent study at the University of Hawaii, Honolulu, conducted a double blind, placebo-controlled study with 108 women lacking sexual desire, age 22 to 73, to determine the role of ArginMax®, a dietary supplement for enhancement of female sexual dysfunction, on sexual function in women (J Sex Marital Ther. 2006;32(5):369-78) (DOI: 10.1080/00926230600834901). Fifty-five women received ArginMax for women, containing L-arginine, ginseng, ginkgo, damiana, mulitvitamins and minerals; and 53 received a placebo, all at different menopausal status. After four weeks, premenopausal women on ArginMax reported significant improvement in their level of sexual desire (p=.03) and satisfaction with overall sex life (p=.03), compared with the placebo group; frequency of sexual desire (p=.05) and frequency of intercourse (p=0.01) also increased. The primary improvements in perimenopausal women was in frequency of intercourse (p=.002), satisfaction with sexual relationship (p=.03) and vaginal dryness (p=.03), compared with the placebo group. Postmenopausal women showed a 51 percent increase in level of sexual desire compared with an 8 percent increase in the placebo group (p=.008). This study will be presented at the American Association of Sexuality Educators, Counselors and Therapists (AASECT) 40th Annual Conference, New Orleans, June 25 to 29, 2008.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like